An ongoing outbreak of Bundibugyo virus disease, a species of orthoebolavirus without approved vaccines or treatments, drives trader focus on confirmed cases through 2026. As of mid-June, the Democratic Republic of the Congo reports over 680 confirmed cases and Uganda nearly 20, following the May declaration of a public health emergency of international concern by WHO; conflict, population displacement, and cross-border movement in Ituri and neighboring provinces elevate transmission risk. Authoritative CDC and WHO surveillance shows no confirmed spread beyond these two nations to date, though South Sudan and other neighbors face elevated monitoring. Weekly ministry and WHO situation reports, plus model projections on case growth, represent key upcoming data that could shift probabilities for additional countries recording at least one laboratory-confirmed case by year-end.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$14,998 Vol.
31 dic 2026
South Sudan
65%
Rwanda
56%
Burundi
48%
United States
42%
Canada
34%
Kenya
58%
India
36%
Republic of the Congo
20%
Nigeria
32%
Ethiopia
42%
Somalia
47%
China
31%
$14,998 Vol.
South Sudan
$597 Vol.
65%
Rwanda
$157 Vol.
56%
Burundi
$163 Vol.
48%
United States
$4,280 Vol.
42%
Canada
$839 Vol.
34%
Kenya
$141 Vol.
58%
India
$390 Vol.
36%
Republic of the Congo
$4,447 Vol.
20%
Nigeria
$24 Vol.
32%
Ethiopia
$64 Vol.
42%
Somalia
$65 Vol.
47%
China
$1,875 Vol.
31%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.An ongoing outbreak of Bundibugyo virus disease, a species of orthoebolavirus without approved vaccines or treatments, drives trader focus on confirmed cases through 2026. As of mid-June, the Democratic Republic of the Congo reports over 680 confirmed cases and Uganda nearly 20, following the May declaration of a public health emergency of international concern by WHO; conflict, population displacement, and cross-border movement in Ituri and neighboring provinces elevate transmission risk. Authoritative CDC and WHO surveillance shows no confirmed spread beyond these two nations to date, though South Sudan and other neighbors face elevated monitoring. Weekly ministry and WHO situation reports, plus model projections on case growth, represent key upcoming data that could shift probabilities for additional countries recording at least one laboratory-confirmed case by year-end.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Mercado abierto: May 22, 2026, 12:35 PM ET
Volumen
$14,998Fecha de finalización
31 dic 2026Mercado abierto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.An ongoing outbreak of Bundibugyo virus disease, a species of orthoebolavirus without approved vaccines or treatments, drives trader focus on confirmed cases through 2026. As of mid-June, the Democratic Republic of the Congo reports over 680 confirmed cases and Uganda nearly 20, following the May declaration of a public health emergency of international concern by WHO; conflict, population displacement, and cross-border movement in Ituri and neighboring provinces elevate transmission risk. Authoritative CDC and WHO surveillance shows no confirmed spread beyond these two nations to date, though South Sudan and other neighbors face elevated monitoring. Weekly ministry and WHO situation reports, plus model projections on case growth, represent key upcoming data that could shift probabilities for additional countries recording at least one laboratory-confirmed case by year-end.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$14,998Fecha de finalización
31 dic 2026Mercado abierto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...An ongoing outbreak of Bundibugyo virus disease, a species of orthoebolavirus without approved vaccines or treatments, drives trader focus on confirmed cases through 2026. As of mid-June, the Democratic Republic of the Congo reports over 680 confirmed cases and Uganda nearly 20, following the May declaration of a public health emergency of international concern by WHO; conflict, population displacement, and cross-border movement in Ituri and neighboring provinces elevate transmission risk. Authoritative CDC and WHO surveillance shows no confirmed spread beyond these two nations to date, though South Sudan and other neighbors face elevated monitoring. Weekly ministry and WHO situation reports, plus model projections on case growth, represent key upcoming data that could shift probabilities for additional countries recording at least one laboratory-confirmed case by year-end.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes